+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
713121-80-3,MFCD05999971
Catalog No.:AA01E519

713121-80-3 | ML-193

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$46.00   $32.00
- +
5mg
≥95%
in stock  
$166.00   $116.00
- +
10mg
≥95%
in stock  
$242.00   $169.00
- +
25mg
≥95%
in stock  
$545.00   $381.00
- +
50mg
≥98%(HPLC)
in stock  
$1,029.00   $720.00
- +
100mg
≥98%(HPLC)
in stock  
$1,736.00   $1,215.00
- +
250mg
≥98%(HPLC)
in stock  
$3,836.00   $2,685.00
- +
500mg
98% by HPLC
in stock  
$5,515.00   $3,861.00
- +
1000mg
98% by HPLC
in stock  
$8,787.00   $6,151.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01E519
Chemical Name:
ML-193
CAS Number:
713121-80-3
Molecular Formula:
C28H25N5O4S
Molecular Weight:
527.5942
MDL Number:
MFCD05999971
SMILES:
Cc1cc(C)c2c(c1)c(cc(n2)c1ccccn1)C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1onc(c1C)C
Properties
Computed Properties
 
Complexity:
921  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
38  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
6  
XLogP3:
4.5  

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Heynen-Genel S, et, al. Screening for Selective Ligands for GPR55-Antagonists. Probe Reports from the NIH Molecular Libraries Program. 2010 Oct 30.

Title: Kotsikorou E, et, al. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry. 2013 Dec 31;52(52):9456-69.

Title: Fatemi I, et, al. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model. Acta Neuropsychiatr. 2021 Feb;33(1):15-21.

Title: Hill JD, et, al. Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol. 2018 Aug;175(16):3407-3421.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 713121-80-3
Building Blocks
More >
Tags:713121-80-3 Molecular Formula|713121-80-3 MDL|713121-80-3 SMILES|713121-80-3 ML-193
Catalog No.: AA01E519
713121-80-3,MFCD05999971
713121-80-3 | ML-193
Pack Size： 1mg
Purity： ≥95%
in stock
$46.00 $32.00
Pack Size： 5mg
Purity： ≥95%
in stock
$166.00 $116.00
Pack Size： 10mg
Purity： ≥95%
in stock
$242.00 $169.00
Pack Size： 25mg
Purity： ≥95%
in stock
$545.00 $381.00
Pack Size： 50mg
Purity： ≥98%(HPLC)
in stock
$1,029.00 $720.00
Pack Size： 100mg
Purity： ≥98%(HPLC)
in stock
$1,736.00 $1,215.00
Pack Size： 250mg
Purity： ≥98%(HPLC)
in stock
$3,836.00 $2,685.00
Pack Size： 500mg
Purity： 98% by HPLC
in stock
$5,515.00 $3,861.00
Pack Size： 1000mg
Purity： 98% by HPLC
in stock
$8,787.00 $6,151.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01E519
Chemical Name: ML-193
CAS Number: 713121-80-3
Molecular Formula: C28H25N5O4S
Molecular Weight: 527.5942
MDL Number: MFCD05999971
SMILES: Cc1cc(C)c2c(c1)c(cc(n2)c1ccccn1)C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1onc(c1C)C
Properties
Complexity: 921  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 38  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 6  
XLogP3: 4.5  
Literature fold

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Heynen-Genel S, et, al. Screening for Selective Ligands for GPR55-Antagonists. Probe Reports from the NIH Molecular Libraries Program. 2010 Oct 30.

Title: Kotsikorou E, et, al. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry. 2013 Dec 31;52(52):9456-69.

Title: Fatemi I, et, al. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model. Acta Neuropsychiatr. 2021 Feb;33(1):15-21.

Title: Hill JD, et, al. Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol. 2018 Aug;175(16):3407-3421.

Related Products of of 713121-80-3
Building Blocks More >
899821-23-9
899821-23-9
ACP-105
AA01E5MV | MFCD31692380
1297271-52-3
1297271-52-3
Lauroyl-d3-L-carnitineHydrochloride
AA01E661
148380-55-6
148380-55-6
5-Acetoxymethyl-2'-deoxyuridine
AA01E6OJ | MFCD22124254
383128-88-9
383128-88-9
2-(TETRAHYDROFURAN-2-YL)PIPERIDINE
AA01E6YD | MFCD02663685
2126162-68-1
2126162-68-1
5-bromo-2-(piperidin-2-yl)pyrimidine hydrochloride
AA01E75H | MFCD30752536
2126160-96-9
2126160-96-9
2-(ethylamino)butanenitrile hydrochloride
AA01E79H | MFCD30752447
2126178-32-1
2126178-32-1
5-bromo-2-(2-hydroxyethyl)-1-benzofuran-7-carboxylic acid
AA01E7CH | MFCD30750876
2126162-67-0
2126162-67-0
2-(3-aminopropyl)-1H-1,3-benzodiazol-5-amine dihydrochloride
AA01E7FD | MFCD30751442
2089257-04-3
2089257-04-3
1-amino-1-cyclopropyl-2-methylpropan-2-ol, trifluoroacetic acid
AA01E7IK | MFCD30537805
2095409-17-7
2095409-17-7
3-(5-fluoropyridin-2-yl)-5-(piperidin-4-ylmethyl)-1,2,4-oxadiazole hydrochloride
AA01E7LR | MFCD30735423
Submit
© 2017 AA BLOCKS, INC. All rights reserved.